Abraham Oler | SVP, Corporate Development & General Counsel |
Steven Fruchtman | CEO, President & Director |
Mark Guerin | CFO |
Sara Nik | H.C. Wainwright |
Ladies and gentlemen, thank you for standing by. Welcome to the Onconova Therapeutics First Quarter Financial Results and Business Update Conference Call. [Operator Instructions].
As a reminder, this call is being recorded today, May 17, 2021. At this time, I would like to turn the call over to Avi Oler, Senior Vice President of Corporate Development and General Counsel.